Authors: Miller, M Ginalski, K Lesyng, B Nakaigawa, N Schmidt, L Zbar, B

Citation: M. Miller et al., Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: Modeling studies, PROTEINS, 44(1), 2001, pp. 32-43

Authors: Danilkovitch-Miagkova, A Miagkov, A Skeel, A Nakaigawa, N Zbar, B Leonard, EJ

Citation: A. Danilkovitch-miagkova et al., Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway, MOL CELL B, 21(17), 2001, pp. 5857-5868

Authors: Nakaigawa, N Weirich, G Schmidt, L Zbar, B

Citation: N. Nakaigawa et al., Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src, ONCOGENE, 19(26), 2000, pp. 2996-3002

Authors: Schmidt, L Junker, K Nakaigawa, N Kinjerski, T Weirich, G Miller, M Lubensky, I Neumann, HPH Brauch, H Decker, J Vocke, C Brown, JA Jenkins, R Richard, S Bergerheim, U Gerrard, B Dean, M Linehan, WM Zbar, B

Citation: L. Schmidt et al., Novel mutations of the MET proto-oncogene in papillary renal carcinomas, ONCOGENE, 18(14), 1999, pp. 2343-2350